Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pfizer Pays $43bn For Seagen With Goal Of Rapidly, Globally Advancing ADCs
Speedy COVID-19 Strategies Will Be Applied In Cancer R&D
Mar 13 2023
•
By
Mandy Jackson
Pfizer's oncology portfolio will grow by four approved drugs and 11 clinical programs • Source: Shutterstock
More from Deals
More from Business